|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Number of the document | 3870213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19801228.8 |
| Date of filing the European patent application | 2019-10-25 | |
| (97) | Date of publication of the European application | 2021-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/079214 |
| Date | 2019-10-25 |
| (87) | Number | WO 2020/084126 |
| Date | 2020-04-30 |
| (30) | Number | Date | Country code |
| 18202801 | 2018-10-26 | EP | |
| 19158226 | 2019-02-20 | EP |
| (72) |
ENGELUND, Dorthe, Kot , DK
JENSEN, Søren, Skov , DK
LUNDQVIST, Joakim , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (54) | STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF |
| STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF |